Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Peoples Bancorp Inc/OH (PEBO)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$39.84+2.26%
Close 2026-11-04 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.15 → 4.18 EPS · FY ending Dec 31, 2027 · 6 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 6; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PEBO yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful integration of Citizens National Corporation acquisition | A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is Acquisition completed and integrated by end of 2026. | Intact | Acquisition fails or integration causes material earnings disruption | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking recovery and acquisition-execution story, rather than a clearly established durable compounder. The thesis is in a watch state: recent performance has improved, but evidence of merger integration and loan growth remains limited.
The valuation evidence points to PEBO being cheap versus peers, with a justified pricing tag and low fragility. The negative expectations gap suggests the market is not fully pricing in the improving business momentum, though the evidence does not show exactly what assumptions investors hold.
Near term, recent earnings beats and a return to the top half of the industry support a recovery in performance. Management has raised its 2026 loan-growth range and is pursuing acquisitions, but the supplied figures do not establish delivery against the loan target or measurable integration results. A guidance cut or rate cuts would weigh on the near-term setup.
Over the next few quarters, the thesis depends on completing and integrating the Citizens and Capital mergers while turning loan-growth guidance into measurable results. Continued strength among financial-sector bellwethers could support sector momentum, while lower rates or a guidance cut would weaken the setup.
For a 1 to 3 year view, PEBO’s recovery has firmer recent evidence, but acquisition execution and sensitivity to rates keep the thesis conditional. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It pays a steady dividend, recently raised to $0.42 per share. |
| Intact |
| dividend per share falls below $0.42 |
Dividend per share: $0.42 per share FY2026-Q3; GAAP. Published target: >= $0.42 per share quarterly. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 20260.42 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS at least $3.42 in fiscal 2026 | A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is >= $3.42 per share. | Intact | EPS falls below $3.42 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Loan growth of 3-5% in fiscal 2026 | A primary condition in Peoples Bancorp Inc/OH's published investment case. The stated target is 3-5% growth. | Broken | loan growth falls below 3% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.85 → $4.18 · observed estimates
$0.53B → $0.77B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.85 | $532,133,330 | 7 / 6 |
| 2026-07-25 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-07-26 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-07-27 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-07-28 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-07-29 | $3.85 | $532,133,330 | 7 / 6 |
| 2026-07-30 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-07-31 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-01 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-02 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-03 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-04 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-05 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-06 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-07 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-08 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-09 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-10 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-12 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-13 | $3.88 | $533,316,670 | 7 / 6 |
| 2026-08-14 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-15 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-16 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-17 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-18 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-19 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-20 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-21 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-22 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-23 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-24 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-25 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-26 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-27 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-28 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-29 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-30 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-08-31 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-01 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-02 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-03 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-04 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-05 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-06 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-07 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-08 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-09 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-10 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-11 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-12 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-13 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-14 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-15 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-16 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-17 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-18 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-19 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-20 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-21 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-22 | $3.88 | $533,316,667 | 6 / 4 |
| 2026-09-23 | $3.89 | $533,316,667 | 6 / 4 |
| 2026-09-24 | $3.89 | $533,316,667 | 6 / 4 |
| 2026-09-25 | $3.89 | $533,799,999 | 6 / 4 |
| 2026-09-26 | $3.89 | $533,799,999 | 6 / 5 |
| 2026-09-27 | $3.89 | $533,799,999 | 6 / 5 |
| 2026-09-28 | $3.89 | $533,799,999 | 6 / 5 |
| 2026-09-29 | $3.89 | $533,799,999 | 6 / 5 |
| 2026-09-30 | $3.89 | $533,799,999 | 6 / 5 |
| 2026-10-01 | $3.98 | $571,416,667 | 6 / 4 |
| 2026-10-02 | $4.08 | $650,833,333 | 4 / 3 |
| 2026-10-03 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-04 | $4.15 | $692,800,000 | 3 / 2 |
| 2026-10-05 | $4.15 | $692,800,000 | 3 / 3 |
| 2026-10-06 | $4.15 | $692,800,000 | 3 / 3 |
| 2026-10-07 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-08 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-09 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-10 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-11 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-12 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-13 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-14 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-15 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-16 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-17 | $4.15 | $692,800,000 | 4 / 3 |
| 2026-10-18 | $4.19 | $731,550,000 | 5 / 4 |
| 2026-10-19 | $4.19 | $731,550,000 | 5 / 4 |
| 2026-10-20 | $4.19 | $731,550,000 | 5 / 4 |
| 2026-10-21 | $4.14 | $730,000,000 | 5 / 4 |
| 2026-10-22 | $4.18 | $767,200,000 | 5 / 4 |
| 2026-10-23 | $4.18 | $767,200,000 | 5 / 4 |
| 2026-10-24 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-25 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-26 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-27 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-28 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-29 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-30 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-10-31 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-11-01 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-11-02 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-11-03 | $4.18 | $767,200,000 | 6 / 4 |
| 2026-11-04 | $4.18 | $767,200,000 | 6 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.